proje değildir.
Aim: The study aims to ascertain whether Anzer Propolis, a natural antioxidant compound, can protect the kidneys from iopromide.
Material and Method: This study was done in 2021. Four groups of 32 adult male Wistar albino rats, weighing between 250 and 300 g, were formed. Control (C) group contained eight rats. Intraperitoneal ethanol was administered to the Ethanol (E) group (n=8), 8 g/kg intraperitoneal iopromide to the contrast-induced nephropathy (CIN) group (n=8), and a 100 mg/kg dose of Anzer Propolis on the date of application to the Anzer Propolis group (AP) (n=8), as well as the prior day, by gastric gavage and then 8 g/kg iopromide was administered intraperitoneally. Termination was carried out at the 48th hour. Histopathological examination was performed for CIN in the right and left kidneys.
Results: Following has been examined as a part of the research: serum urea, creatinine, IL6, interleukin (IL)-1β, total oxidant status (TOS), tumor necrosis factor (TNF-α), total antioxidant status (TAS), myeloperoxidase (MPO). TAS had a statistically significant increase in AP, in comparison to CIN, C and E groups (p<0.05). The pathological examination showed, vacuolar degeneration formations in tubular epithelial cells, and increase in mononuclear cell infiltration areas in the interstitial region in CIN. CIN had significantly higher values in comparison to AP (p<0.05).
Conclusion: Propolis protects the kidney tissue against the toxicity caused by CIN and negative effects of free radicals; most likely due to the antioxidant and antitoxic properties. Propolis is a promising natural substance for preventing CIN. There is a need for further research on the properties of propolis.
Anzer propolis contrast induced nephropathy acute kidney injury rat
Etik kurul onayı eklenmiştir.
yok
proje değildir.
Çalışmada emeği geçen herkese teşekkür ederiz.
| Birincil Dil | İngilizce |
|---|---|
| Konular | Nefroloji |
| Bölüm | Klinik Araştırma |
| Yazarlar | |
| Proje Numarası | proje değildir. |
| Gönderilme Tarihi | 17 Kasım 2023 |
| Kabul Tarihi | 9 Şubat 2024 |
| Yayımlanma Tarihi | 16 Mayıs 2024 |
| DOI | https://doi.org/10.37990/medr.1392143 |
| IZ | https://izlik.org/JA64ZN88FS |
| Yayımlandığı Sayı | Yıl 2024 Cilt: 6 Sayı: 2 |
Chief Editors
Prof. Dr. Berkant Özpolat, MD
Department of Thoracic Surgery, Ufuk University, Dr. Rıdvan Ege Hospital, Ankara, Türkiye
Editors
Prof. Dr. Sercan Okutucu, MD
Department of Cardiology, Ankara Lokman Hekim University, Ankara, Türkiye
Assoc. Prof. Dr. Süleyman Cebeci, MD
Department of Ear, Nose and Throat Diseases, Gazi University Faculty of Medicine, Ankara, Türkiye
Field Editors
Assoc. Prof. Dr. Doğan Öztürk, MD
Department of General Surgery, Manisa Özel Sarıkız Hospital, Manisa, Türkiye
Assoc. Prof. Dr. Birsen Doğanay, MD
Department of Cardiology, Ankara Bilkent City Hospital, Ankara, Türkiye
Assoc. Prof. Dr. Sonay Aydın, MD
Department of Radiology, Erzincan Binali Yıldırım University Faculty of Medicine, Erzincan, Türkiye
Language Editors
PhD, Dr. Evin Mise
Department of Work Psychology, Ankara University, Ayaş Vocational School, Ankara, Türkiye
Dt. Çise Nazım
Department of Periodontology, Dr. Burhan Nalbantoğlu State Hospital, Lefkoşa, North Cyprus
Statistics Editor
Dr. Nurbanu Bursa, PhD
Department of Statistics, Hacettepe University, Faculty of Science, Ankara, Türkiye
Scientific Publication Coordinator
Kübra Toğlu
argistyayincilik@gmail.com
Franchise Owner
Argist Yayıncılık
argistyayincilik@gmail.com
Publisher: Argist Yayıncılık
E-mail: argistyayincilik@gmail.com
Phone: 0312 979 0235
GSM: 0533 320 3209
Address: Kızılırmak Mahallesi Dumlupınar Bulvarı No:3 C-1 160 Çankaya/Ankara, Türkiye
Web: www.argistyayin.com.tr